Lumos Pharma Inc’s filing revealed that its Chief Scientific Officer McKew John C. unloaded Company’s shares for reported $6426.0 on Aug 06 ’24. In the deal valued at $1.89 per share,3,407 shares were sold. As a result of this transaction, McKew John C. now holds 12,653 shares worth roughly $49346.7.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, McKew John C. sold 2,214 shares, generating $6,144 in total proceeds. Upon selling the shares at $2.77, the Chief Scientific Officer now owns 17,153 shares.
Before that, McKew John C. sold 438 shares. Lumos Pharma Inc shares valued at $1,328 were divested by the Chief Scientific Officer at a price of $3.03 per share. As a result of the transaction, McKew John C. now holds 18,403 shares, worth roughly $71771.7.
Stifel upgraded its Lumos Pharma Inc [LUMO] rating to a Buy from a a Hold in a research note published on March 11, 2021; the price target was increased to $24 from $4. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in early December with a ‘”a Buy”‘ rating. Piper Sandler began covering LUMO with “an Overweight” recommendation on August 26, 2020.
Price Performance Review of LUMO
On Tuesday, Lumos Pharma Inc [NASDAQ:LUMO] saw its stock jump 1.30% to $3.90. Over the last five days, the stock has gained 27.87%. Lumos Pharma Inc shares have risen nearly 22.64% since the year began. Nevertheless, the stocks have risen 30.00% over the past one year. While a 52-week high of $4.55 was reached on 08/26/24, a 52-week low of $1.37 was recorded on 07/10/24. SMA at 50 days reached $2.18, while 200 days put it at $2.69.
Levels Of Support And Resistance For LUMO Stock
The 24-hour chart illustrates a support level at 3.45, which if violated will result in even more drops to 3.00. On the upside, there is a resistance level at 4.28. A further resistance level may holdings at 4.65. The Relative Strength Index (RSI) on the 14-day chart is 82.27, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.92, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 20.57%. Stochastics%K at 85.78% indicates the stock is a selling.
How much short interest is there in Lumos Pharma Inc?
A steep rise in short interest was recorded in Lumos Pharma Inc stocks on 2024-07-31, growing by 0.15 million shares to a total of 0.45 million shares. Yahoo Finance data shows the prior-month short interest on 2024-06-28 was 0.29 million shares. There was a rise of 34.4%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 04, 2020 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $33 price target.
